SLC2A1 and colorectal cancer: (64) found that lncRNA RAD51-AS1 can inhibit the miR-29b/c-3p/NDRG2 signal axis and the expression of hexokinase 2 and GLUT1, thereby inhibiting the progression of colorectal cancer.